John Campbell

Company: Stealth BioTherapeutics

Job title: Executive Director - Clinical Development

Seminars:

Using Natural History Studies for Rare Mitochondrial Diseases to Bolster Study Design 1:00 pm

Natural history studies are vital to all drug development projects but are especially difficult to obtain for inherited mitochondrial diseases due to their severity and rarity Discussing the power of natural history diseases to understand disease prevalence study disease progression and improve the efficiency of drug development Utilising natural history studies in conjunction to clinical…Read more

day: Day Two